Is Malignant Dedifferentiation for Mucinous Appendiceal Neoplasms a Valid Phenomenon or Merely Histopathologic Ambiguity?
Authors:
- Kanwal P.S. RaghavKRKanwal P.S. Raghav
- Melissa W. TaggartMTMelissa W. Taggart
- Keith F. FournierKFKeith F. Fournier
- Michael J. OvermanMOMichael J. Overman
- 1 May 2011
- journal article
- other
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 212 (5) , 906
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Secondary Cytoreduction and Perioperative Intraperitoneal Chemotherapy after Initial Debulking of Pseudomyxoma Peritonei: A Study of Timing and the Impact of Malignant DedifferentiationJournal of the American College of Surgeons, 2010
- Pseudomyxoma Peritonei of Appendiceal Origin: A Clinicopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, With Literature ReviewAmerican Journal of Surgical Pathology, 2006
- Appendiceal Mucinous NeoplasmsAmerican Journal of Surgical Pathology, 2003
- Histopathologic Analysis in 46 Patients with Pseudomyxoma Peritonei Syndrome: Failure versus Success with a Second-Look OperationLaboratory Investigation, 2001
- A Clinicopathologic Analysis of 109 Cases with Emphasis on Distinguishing Pathologic Features, Site of Origin, Prognosis, and Relationship to “Pseudomyxoma Peritonei”American Journal of Surgical Pathology, 1995